Flexible Implantable Depots for Sustained Analgesic Release
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing implantable systems for therapeutic agent delivery suffer from a lack of controlled release mechanisms, often resulting in burst release followed by residual release, which can lead to undesirable systemic side effects.
Innovation Solution
The development of implantable depots with a therapeutic region surrounded by control regions, utilizing biodegradable polymers and optional plasticizers, to achieve a sustained and controlled release of therapeutic agents, such as analgesics, by modulating release through polymer degradation and fluid interaction.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If implantable systems use simple polymer matrices for therapeutic agent delivery, then manufacturing is easier and device complexity is reduced, but controlled release mechanism is lacking resulting in burst release
Solution Approach 1:
The implantable system is segmented into distinct functional layers: a therapeutic agent-loaded polymer matrix layer and a controlling layer with controlled porosity. This segmentation allows each layer to perform its specific function - the matrix layer provides easy manufacturing and drug loading, while the controlling layer provides the reliable controlled release mechanism by regulating fluid penetration and drug diffusion rates.
Solution Approach 2:
The system uses composite material structure combining a biodegradable polymer matrix (such as PLGA) with a controlling layer having controlled porosity. This composite structure integrates the manufacturing advantages of polymer matrices with the controlled release properties of porous structures, resolving the contradiction between ease of manufacture and reliable controlled release.
2Speed
If implantable systems provide burst release of therapeutic agent, then initial therapeutic effect is achieved quickly, but systemic side effects increase
Solution Approach 1:
The controlling layer is positioned locally between the therapeutic agent reservoir and the surrounding tissue environment. This local quality control allows the system to manage release kinetics at the implant site, providing rapid initial therapeutic effect when needed while simultaneously preventing excessive systemic absorption through the controlled porosity structure.
Solution Approach 2:
The controlling layer with controlled porosity acts as an intermediary between the therapeutic agent-loaded matrix and the surrounding physiological environment. It mediates the release process by regulating fluid penetration and drug diffusion, enabling burst release when appropriate while preventing harmful systemic side effects through controlled transport properties.
3Duration of action of stationary object
If implantable depots use biodegradable polymers for controlled release, then sustained release over time is achieved, but flexibility and handling properties deteriorate
Solution Approach 1:
The implantable depot utilizes thin film structures with controlled porosity for the controlling layer. These thin films maintain flexibility and ease of handling during implantation while providing the necessary sustained release duration through their controlled porosity and biodegradable polymer composition. The thin film geometry allows the device to be easily implanted while achieving long-term controlled release.
Solution Approach 2:
The system adjusts physical parameters such as film thickness, porosity, and polymer composition to balance sustained release duration with flexibility and handling properties. By optimizing these parameters, the controlling layer can provide extended release over time while maintaining the mechanical flexibility needed for easy implantation and handling during surgical procedures.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The implantable depots provide a highly controlled, sustained release of therapeutic agents, reducing systemic side effects and enhancing treatment efficacy by tailoring release profiles to medical conditions and therapeutic agents, as demonstrated by in vivo and in vitro data.
Implementation Method 1
Devices made of biocompatible and/or biodegradable polymers and therapeutic agents can be implanted in clinically desirable anatomic locations
Implementation Method 2
This localized delivery enables a substantial proportion of the agent to reach the intended target
Data Source
AI summary
Implantable depots for delivering therapeutic agents and associated systems and methods are provided. In some embodiments, an implantable depot for treating pain includes a therapeutic region including a polymer, an analgesic agent, and a plasticizer. When implanted in vivo, the therapeutic region can be configured to release the analgesic agent for a treatment period of at least 3 days. The implantable depot can have a flexural modulus within a range from 1 MPa to 400 MPa.